Trademark Overview
On Thursday, September 4, 2025, a trademark application was filed for GENE THERAPY FOR THE MASSES with the United States Patent and Trademark Office. The USPTO has given the GENE THERAPY FOR THE MASSES trademark a serial number of 99375244. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, February 10, 2026. This trademark is owned by Pacira Therapeutics, Inc.. The GENE THERAPY FOR THE MASSES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for gene therapy for the treatment of inflammation, pain, osteoarthritis, musculoskeletal conditions and disorders, and soft tissue conditions and disorders; Pharmaceutical preparations for the treatment and prevention of inflammation, pain, osteoarthritis, musculoskeletal conditions and disorders, and soft tissue conditions and disorders; Therapeutic pharmaceutical for the treatment of inflammation, pain, osteoarthritis, musculoskeletal conditions and disorders, and soft tissue conditions and disorders
Providing scientific information in the field of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; Medical and scientific research information in the field of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; Drug discovery services; Pharmaceutical research and development; Research and development of new products
